According to Persistence Market Research, the global Chemotherapy Drugs market will grow from its market size of US$ 56.1 Bn in 2025 to US$ 102.5 Bn in 2032, with a CAGR of 9.0% during the same period.
Chemotherapy drugs are used to destroy or slow the growth of cancer cells, either alone or alongside surgery, radiation, or immunotherapy. The market is expected to grow due to rising cancer prevalence, increased awareness, and better healthcare access. Key drivers include the increased regulatory approvals and government initiatives for chemotherapy drugs.